Table 3.
Asthma exacerbation in hospitals from different geographic zones.
| North zone | Central zone | South zone | p | |
|---|---|---|---|---|
| Median days of hospital stay | 6 (1–18) | 4 (1–20) | 4 (2–20) | <0.001 |
| Median days of PICU | 3 (1–12) | 4 (1–10) | 3 (1–7) | 0.859 |
| Median days of NIV | 2 (1–2) | 3 (2–4) | 3 (2–4) | 0.421 |
| Median days of O2 | 5 (1–14) | 3 (1–13) | 2 (1–8) | <0.001 |
| Median days of systemic corticosteroids | 5 (1–10) | 4 (1–20) | 4 (1–14) | <0.001 |
| Number of patients receiving antibiotics | 31 (86.1%) | 98 (32.6%) | 30 (50.9%) | <0.001 |
| Number of patients with complications | 26 (72.2%) | 70 (23.3%) | 5 (8.5%) | <0.001 |
| Number of complications | 38 | 78 | 7 | |
| Atelectasis (ATL) | 8 (13.1%) | 49 (80.3%)* | 4 (6.6%) | <0.0001* |
| Bronchopneumonia | 23 (45.1%) | 25 (49.0%) | 3 (5.9%)* | <0.004* |
| Pleural effusion | 4 (100%)* | 0 (0%) | 0 (0%) | 0.0031 |
| Pneumomediastinum | 0 (0%) | 1 (100%) | 0 (0%) | NS |
| Pneumothorax | 1 (33.3%) | 2 (66.7%) | 0 (0%) | NS |
| Subcutaneous emphysema | 2 (66.7%) | 1 (33.3%) | 0 (0%) | NS |
NS: non-significant.
*
Value differs significantly